Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Active Comparator-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement

NCT00641732 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00641732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00641732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Active Comparator-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement
Lead sponsor
Takeda
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
October 31, 2008
Enrollment
1,045 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism